Published in Chest on May 01, 1998
Airway mucus function and dysfunction. N Engl J Med (2010) 4.41
Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am J Respir Crit Care Med (2013) 2.09
Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS One (2011) 1.58
Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest (2012) 1.50
Bronchiectasis--diagnosis and treatment. Dtsch Arztebl Int (2011) 1.43
Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest (2010) 1.34
Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.29
Diagnosis and management of primary ciliary dyskinesia. Arch Dis Child (2014) 1.26
The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis (2009) 1.18
Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases. BMC Infect Dis (2011) 1.18
Diagnosis and management of primary ciliary dyskinesia. Cilia (2015) 1.14
Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax (2005) 1.12
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax (2013) 1.12
Clinical issues of mucus accumulation in COPD. Int J Chron Obstruct Pulmon Dis (2014) 0.99
Cigarette smoke and CFTR: implications in the pathogenesis of COPD. Am J Physiol Lung Cell Mol Physiol (2013) 0.96
Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients. Respir Res (2012) 0.91
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis. J Inflamm Res (2013) 0.91
Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol (2015) 0.91
Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency. Clin Exp Immunol (2009) 0.88
Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection. J Thorac Dis (2015) 0.82
Primary ciliary dyskinesia. Semin Respir Crit Care Med (2015) 0.82
Treatment of bronchiectasis in adults. BMJ (2007) 0.80
Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression. PLoS One (2015) 0.80
The EMBARC European Bronchiectasis Registry: protocol for an international observational study. ERJ Open Res (2016) 0.80
Bronchiectasis. BMJ Clin Evid (2011) 0.79
Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial. Trials (2012) 0.79
Primary Ciliary Dyskinesia. Clin Chest Med (2016) 0.77
The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis. Mediators Inflamm (2012) 0.77
Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis. Mediators Inflamm (2014) 0.76
Bronchiectasis. BMJ Clin Evid (2008) 0.76
Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance. Clin Chest Med (2015) 0.76
Efficacy and safety of nebulized recombinant human DNase as rescue treatment for persistent atelectasis in newborns: case-series. Croat Med J (2007) 0.76
Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial. PLoS One (2016) 0.75
Chest pain and exacerbations of bronchiectasis. Int J Gen Med (2012) 0.75
The Likelihood of Preventing Respiratory Exacerbations in Children and Adolescents with either Chronic Suppurative Lung Disease or Bronchiectasis. Front Pediatr (2017) 0.75
Bronchiectasis. BMJ Clin Evid (2015) 0.75
Bronchiectasis, part 2: Management. J Respir Dis (2008) 0.75
To investigate the prevention of OM-85 on bronchiectasis exacerbations (iPROBE) in Chinese patients: study protocol for a randomized controlled trial. Trials (2014) 0.75
Genetics, diagnosis, and future treatment strategies for primary ciliary dyskinesia. Expert Opin Orphan Drugs (2014) 0.75
Adrenal reserve in acute exacerbation of non-cystic fibrosis bronchiectasis. Indian J Med Res (2015) 0.75
The role of the high-sensitivity C-reactive protein in patients with stable non-cystic fibrosis bronchiectasis. Pulm Med (2013) 0.75
Diagnosis and management of bronchiectasis. CMAJ (2017) 0.75
Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung. Sci Rep (2017) 0.75
The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis. Ann Thorac Med (2017) 0.75
What's new in the management of adult bronchiectasis? F1000Res (2017) 0.75
Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med (1999) 3.34
The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med (1997) 2.28
Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J Clin Invest (1984) 1.86
Clostridium difficile infection as a cause of severe sepsis. Intensive Care Med (1996) 1.75
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med (1997) 1.71
Benefits of a multidisciplinary pulmonary rehabilitation program. Improvements are independent of lung function. Chest (1991) 1.59
Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay. J Clin Invest (1981) 1.57
Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.51
The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med (1994) 1.44
Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect Immun (1993) 1.40
Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol (1997) 1.29
IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis. J Infect Dis (1985) 1.25
Cystic fibrosis. J Clin Invest (1987) 1.24
Campylobacter fetus septic arthritis: report of a case. Yale J Biol Med (1979) 1.24
Bronchoalveolar lavage. Thorax (1980) 1.18
Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr Res (1986) 1.17
Use of Pseudomonas aeruginosa lipopolysaccharide immunoadsorbents to prepare high potency, mono-specific antibodies. J Immunol Methods (1980) 1.12
Bilateral upper lobe Pneumocystis carinii pneumonia in a patient receiving inhaled pentamidine prophylaxis. Chest (1988) 1.10
Respiratory effects of timolol. N Engl J Med (1984) 1.10
Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med (1996) 1.03
Catamenial hemoptysis. New methods of diagnosis and therapy. Chest (1985) 1.01
Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide. Am Rev Respir Dis (1986) 0.97
Alterations in the antibacterial properties of rabbit pulmonary macrophages exposed to wood smoke. Am Rev Respir Dis (1984) 0.92
Biologic activity of purified cotton bract extracts in man and guinea pig. Environ Health Perspect (1986) 0.91
Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase. J Lab Clin Med (1989) 0.90
Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease. Dis Markers (1991) 0.89
Dual pathway clearance of 99mTc-DTPA from the bronchial mucosa. Am Rev Respir Dis (1989) 0.87
Airway adherence of Pseudomonas aeruginosa: mucoexopolysaccharide binding to human and bovine airway proteins. J Lab Clin Med (1991) 0.87
Rapidly developing cavitating pulmonary metastases. Chest (1979) 0.87
Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency. Am J Epidemiol (2009) 0.86
IgE inhibition as a therapy for allergic disease. Int Arch Allergy Immunol (1999) 0.86
The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion. J Clin Invest (1990) 0.86
Heritability of lung function in severe alpha-1 antitrypsin deficiency. Hum Hered (2008) 0.86
Demonstration of a free elastolytic metalloenzyme in human lung lavage fluid and its relationship to alpha 1-antiprotease. Am Rev Respir Dis (1984) 0.85
Pseudomonas aeruginosa and the airways disease of cystic fibrosis. Clin Chest Med (1988) 0.84
Regional deposition of aerosolized pentamidine. Effects of body position and breathing pattern. Ann Intern Med (1990) 0.84
Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med (2000) 0.84
Antibody to multiple mucoid strains of Pseudomonas aeruginosa in patients with cystic fibrosis, measured by an enzyme-linked immunosorbent assay. Pediatr Res (1986) 0.83
Modelling asthma in macaques: longitudinal changes in cellular and molecular markers. Eur Respir J (2010) 0.83
Treatment of allergic airways disease with anti-IgE. Allergy (1998) 0.82
Pseudomonas in cystic fibrosis sylph or sycophant? Clin Chest Med (1981) 0.82
Changing spectrum of pneumonia--news media creation or clinical reality? Am J Med (1983) 0.82
Post-traumatic bronchial stenosis and acute respiratory insufficiency. J Thorac Cardiovasc Surg (1980) 0.82
Humoral immunity in bronchiectasis. Ann Allergy (1987) 0.81
Inspiratory flow rate and dynamic lung function in cystic fibrosis and chronic obstructive lung diseases. Chest (1998) 0.81
Ingestion of hydroxyethyl starch by human leukocytes. Transfusion (1986) 0.81
Candidacidal factors in murine bronchoalveolar lavage fluid. Infect Immun (1987) 0.81
Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody? Bull Eur Physiopathol Respir (1983) 0.81
Pulmonary arteriovenous fistulas occluded by percutaneous introduction of coil springs. Radiology (1984) 0.80
Pulmonary rehabilitation in the elderly patient. Clin Chest Med (1993) 0.78
Hepatogenic pulmonary angiodysplasia treated with coil-spring embolization. Chest (1987) 0.78
Nonbacterial thrombotic endocarditis associated with bone marrow transplantation. Chest (1986) 0.78
Percutaneous interventional catheter therapy for lesions of the chest and lungs. Chest (1982) 0.77
Pathogenetic mechanisms in cystic fibrosis lung disease: a paradigm for inflammatory airways disease. J Lab Clin Med (1993) 0.77
Cardiac arrhythmias during the combined use of beta-adrenergic agonist drugs and theophylline. Chest (1986) 0.77
Nontuberculous mycobacterial lung disease. Substantiation of a less aggressive approach. Chest (1988) 0.77
Cell-mediated antibacterial defenses of the distal airways. Am Rev Respir Dis (1985) 0.76
Chylothorax as a complication of oesophageal sclerotherapy. Thorax (1992) 0.75
Bronchoalveolar lavage in allergic asthmatics. Am Rev Respir Dis (1987) 0.75
Strategies in managing asthma. West J Med (1989) 0.75
Penetration of cefotaxime into respiratory secretions. Antimicrob Agents Chemother (1987) 0.75
Immunoglobulin-E and anti-IgE treatment in lung disease. Monaldi Arch Chest Dis (2001) 0.75
Introduction: cystic fibrosis lung disease: evolving concepts. Semin Respir Infect (1992) 0.75
Chronic lung disease associated with Mycobacterium chelonei in an Indochinese refugee. Clin Notes Respir Dis (1982) 0.75
Immunomodulatory therapies for cystic fibrosis. Semin Respir Infect (1992) 0.75
Are lymphocyte beta-adrenoceptors altered in patients with cystic fibrosis? Clin Sci (Lond) (1987) 0.75
Bronchoscopy and bone marrow examinations. An efficient strategy to establish the diagnosis of small cell carcinoma of the lung. Chest (1981) 0.75
Animals in medical research. Official statement of the American Thoracic Society. Am Rev Respir Dis (1991) 0.75
Alpha-l-antitrypsin deficiency presenting as bronchiectasis. Br J Dis Chest (1986) 0.75
Letter: Antibiotic regimen for lung abscess. Chest (1975) 0.75
Prevention of recurrent venous thrombosis: warfarin versus heparin. N Engl J Med (1980) 0.75
Clinical and laboratory management of pulmonary embolism. Geriatrics (1983) 0.75
Longitudinal evaluation of a patient with arteriovenous fistulas. Use of FRC-TLC shunt technique. Chest (1979) 0.75
Hypogammaglobulinemia in cystic fibrosis. N Engl J Med (1980) 0.75